# US 2018/0021445 A1 · Use of p97 as an enzyme delivery system for the delivery of therapeutic lysosomal enzymes

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2018/0021445 A1
- Document ID: US20180021445A1
- Status: Published application
- Kind: A1
- Application number: 15/445,375
- Filed: 2017-02-28
- Published: 2018-01-25
- Earliest claimed: 2002-01-11
- Assignees: Bioasis Technologies, Inc.
- Applicants: biOasis Technologies, Inc.
- Inventors: Christopher M. Starr; Todd Zankel
- Web page: https://patentgrep.com/patent/US20180021445A1

## CPC

- A61K 47/64: Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent (peptidic linkers A61K47/65)
- A61K 38/465: {acting on ester bonds (3.1), e.g. lipases, ribonucleases}
- A61K 38/47: acting on glycosyl compounds (3.2), e.g. cellulases, lactases
- A61P 3/00: Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P7/00)
- C12Y 302/01076: L-Iduronidase (3.2.1.76)
- G01N 33/5008: {for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics}
- G01N 33/5035: {on sub-cellular localization}
- G01N 33/5058: {Neurological cells}
- G01N 33/566: using specific carrier or receptor proteins as ligand binding reagents {where possible specific carrier or receptor proteins are classified with their target compounds}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C12Y: ENZYMES
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

The present invention provides for compositions and methods for treating, ameliorating or preventing a lysosomal storage disease by administering to a patient suffering front a lysosomal storage disease a P97 conjugated with art enzyme which is capable of transportation into the lysosomes of cells on either sides of the blood brain barrier.

## Claims

### Claim 1

A method for treating a subject having a lysosomal storage disease, said method comprising
administering a pharmaceutical composition to the subject wherein the composition comprises a p97 molecule covalently linked to a protein whose deficiency causes the disease.

### Claim at position 2

2-13. (canceled)

### Claim 14

A compound comprising a p97 molecule covalently linked to a protein whose deficiency causes a lysosomal storage disease.

### Claim at position 4

15-20. (canceled)

### Claim 21

A method of screening a compound for therapeutic activity in treating a lysosomal storage disease, said method comprising:
contacting a cell having a lysosome with the compound, wherein the compound comprises p97 covalently linked to a protein deficient in a lysosomal storage disease; and
monitoring delivery of the compound to the lysosome.

### Claim at position 6

22-29. (canceled)
